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Abstract
Transcarbamylases reversibly transfer a carbamyl group from carbamylphosphate (CP) to an amine. Although aspartate
transcarbamylase and ornithine transcarbamylase (OTC) are well characterized, little was known about putrescine
transcarbamylase (PTC), the enzyme that generates CP for ATP production in the fermentative catabolism of agmatine. We
demonstrate that PTC (from Enterococcus faecalis), in addition to using putrescine, can utilize L-ornithine as a poor
substrate. Crystal structures at 2.5 A ˚ and 2.0 A ˚ resolutions of PTC bound to its respective bisubstrate analog inhibitors for
putrescine and ornithine use, N-(phosphonoacetyl)-putrescine and d-N-(phosphonoacetyl)-L-ornithine, shed light on PTC
preference for putrescine. Except for a highly prominent C-terminal helix that projects away and embraces an adjacent
subunit, PTC closely resembles OTCs, suggesting recent divergence of the two enzymes. Since differences between the
respective 230 and SMG loops of PTC and OTC appeared to account for the differential preference of these enzymes for
putrescine and ornithine, we engineered the 230-loop of PTC to make it to resemble the SMG loop of OTCs, increasing the
activity with ornithine and greatly decreasing the activity with putrescine. We also examined the role of the C-terminal helix
that appears a constant and exclusive PTC trait. The enzyme lacking this helix remained active but the PTC trimer stability
appeared decreased, since some of the enzyme eluted as monomers from a gel filtration column. In addition, truncated PTC
tended to aggregate to hexamers, as shown both chromatographically and by X-ray crystallography. Therefore, the extra C-
terminal helix plays a dual role: it stabilizes the PTC trimer and, by shielding helix 1 of an adjacent subunit, it prevents the
supratrimeric oligomerizations of obscure significance observed with some OTCs. Guided by the structural data we identify
signature traits that permit easy and unambiguous annotation of PTC sequences.
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Introduction
Transcarbamylation is a key enzymatic function for essentially all
life forms. Carbamylphosphate (CP), an energy-rich compound that
may have originated in the prebiotic world [1], is the source of a
carbamyl group for incorporation into organic molecules that are
crucial for virtually all life forms, like pyrimidines or arginine [2].
Transcarbamylases are the enzymes that carry out this work, by
carbamylating an amine using as donor the carbamyl group of CP.
These carbamyl group incorporations are mediated by aspartate
transcarbamylase (ATC) or ornithine transcarbamylase (OTC) and
its variant forms using aN-acetyl- or aN-succinyl-L-ornithine [3,4].
However, transcarbamylases are not only used as biosynthetic
enzymes.Catabolictranscarbamylasesexploit the reversibilityofthe
transcarbamylation reaction, deriving energy fermentatively from
carbamyl-group containing organic compounds [5–12]. Thus,
many microorganisms catabolize arginine by a pathway (the
arginine deiminase pathway) (Figure 1A) using a catabolic OTC
[5,6]. Similarly, agmatine, the decarboxylated analogue of arginine,
can be used as a fermentative source of ATP utilizing putrescine
transcarbamylase (PTC) in this process (Figure 1B) [7–9]. Such
process may endow with resistance to acidic pHs to the organisms
hosting it, like the caries-producing Streptococcus mutans [13] or the
food pathogen Listeria monocytogenes [14]. In another similar
fermentative process, allantoin, a purine catabolite of many
mammals, or its degradation product oxalurate, can be utilized as
energy source in a pathway involving oxamate transcarbamylase
[10–12]. In all these cases the transcarbamylase makes CP from the
carbamyl group-containing compound and phosphate, and this CP
is then used for phosphorylating ADP in a reaction catalyzed by the
enzyme carbamate kinase (Figure 1).
Surprisingly, despite the fact that transcarbamylases catalyzing
CP production from carbamyl group-containing compounds have
been known for many years already, only one catabolic
transcarbamylase, OTC, was studied in detail (see for example
[15,16]). Quite limited information, which does not include
structural data, exists, for example, about PTC [7,9], despite the
fact that inhibition of agmatine catabolism in S. mutans might be
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known about oxamate transcarbamylase other than its occur-
rence in a number of microorganisms like Enterococcus faecalis
[10,11], a coccus that can cause opportunistic infections and is
sensitive to very few antibiotics [18], and which also has the
agmatine deiminase and arginine deiminase catabolic pathways
[5,8,11]. In the case of oxamate transcarbamylase not even its
gene has been identified, whereas the gene for PTC was identified
[19,20] and positively proven to encode this enzyme just few
years ago [9].
We have undertaken the task of characterizing structurally
catabolic transcarbamylases that are presently not well under-
stood. We report here the crystal structure at 2.5 A ˚ resolution of
PTC from E. faecalis bound to a bisubstrate analogue inhibitor [9],
N-(phosphonoacetyl)-putrescine (PAPU, Figure 1C). This trans-
carbamylase has the additional interest of not being completely
Figure 1. Arginine deiminase and agmatine deiminase pathways and bisubstrate analog inhibitors of OTC and PTC. Representation of
agmatine (A) and arginine (B) fermentation routes with the chemical structure of the compounds involved and the cartoon diagrams of the known protein
structures: E. faecalis AgDI (2JER), P. aeruginosa ADI (1RXX), E. coli OTC (2OTC) and E. faecalis CK (2WE5). (C) Inert bisubstrate analog inhibitors for OTC and for
PTC, PALO and PAPU, respectively. The carbamylphosphate moiety of each inhibitor is colored red and the putrescine or the ornithine moiety in black.
doi:10.1371/journal.pone.0031528.g001
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ornithine as a poor substrate in addition to using its genuine
substrate putrescine, raising the issue of whether OTC and PTC
evolved from a common ancestor not differentiating between L-
ornithine and its decarboxylated analogue putrescine or whether
PTC derives from OTC in an as yet incomplete process of
changing specificity from ornithine to putrescine. The structural
closeness of PTC to the OTC of Pyrococcus furiosus would appear to
support the second possibility. In any case, we clarify here which
structural elements determine the preference of the enzyme for
putrescine. Furthermore, our present determination of the crystal
structure at 2.0 A ˚ resolution of the complex of PTC with the
corresponding bisubstrate analogue for ornithine use, d-N-
(phosphonoacetyl)-L-ornithine (PALO, Figure 1C), explains why
this enzyme can use ornithine. These findings shed light on how
PTC became able to use an amine not having a carboxylate group,
providing hints on how to engineer transcarbamylases to change
their specificity. Such engineering is illustrated here by our
reversion of the substrate preference of PTC, rendering the
enzyme a better OTC and a much poorer PTC.
On the basis of the structure we highlight here some sequence
traits that appear diagnostic of PTCs and that may ease
recognition of this enzyme in sequence databases. Among these
traits, one concerns an unexpected structural feature, the presence
of a very prominent C-terminal helix that interlinks adjacent
subunits in the PTC trimer. Sequence comparisons indicate that
this helix, which has not been found in any other transcarbamyl-
ase, is constant among PTCs. We prove here by in silico studies
and by helix deletion and experimental investigations (including
X-ray crystallography of the truncated enzyme) that this C-
terminal helix plays paramount roles in trimer stabilization and in
the prevention of formation of supratrimeric oligomers similar to
those seen with some OTCs [15,16,21]. This raises the question of
which is the significance of higher oligomer formation among
transcarbamylases.
Another intriguing feature requiring functional clarification is
our present finding of one Ni atom binding at the trimer threefold
axis, at a site similar to the ones found in the catabolic OTCs from
Lactobacillus hilgardii [16] and Giardia lamblia [22]. The finding of
metals binding in these OTCs and the report that rat OTC is a
conspicuous cadmium-binding liver protein [23] warrants the
study of the significance of the metal interactions of transcarba-
mylases.
Results and Discussion
PTC genuinely uses ornithine as substrate
We conclusively confirm a previous report [7] that PTC uses L-
ornithine as a poor substrate. The possibility that this activity were
due to traces of putrescine contaminating the ornithine was
excluded by bringing the reaction with ornithine to equilibrium
with large amounts of recombinant PTC, comparing the results
with those obtained with pure recombinant OTC (from Enterococ-
cus faecalis) (Figure 2A). The same equilibrium point was attained
with both enzymes, judged by measuring citrulline, corresponding
to ,90% conversion of ornithine to citrulline. If the activity had
been due to traces of contaminating putrescine a much lower
concentration of the carbamylated product (carbamylputrescine
and citrulline give similar color in the Archibald reaction used [9])
would have been obtained at equilibrium with PTC. The
alternative artifactual possibility for ornithine use by PTC, that
the PTC preparation were contaminated by traces of OTC, was
excluded (Figure 2B) by showing that the PTC-specific bisubstrate
analogue inhibitor PAPU inhibited similarly the activities of PTC
with putrescine and with ornithine whereas this compound did not
substantially inhibit citrulline synthesis by purified OTC. A further
definitive proof for the responsibility of PTC for using ornithine
was provided by mutation of one residue of the active center of this
enzyme. The R54G mutant prepared by site-directed mutagenesis
(see Materials and Methods) did not exhibit any PTC or OTC
activity despite the fact that it was highly soluble and was purified
to homogeneity similarly to the wild-type enzyme (detection limit
of the activity assay, 1,000-fold lower activity than wild-type PTC).
Indeed, the determination of the crystal structure of PTC bound to
Figure 2. PTC carbamylates ornithine in addition to putrescine. (A) Approach to equilibrium in the carbamylation of ornithine (open
symbols) using either OTC (squares) or PTC (triangles) from E. faecalis as catalyst and comparison with the equilibrium for putrescine carbamylation
catalyzed by PTC (closed symbols). Tubes containing the indicated amounts of either OTC or PTC in 0.25 ml of 0.1 M Tris-HCl pH 8.5, 0.4 mg/ml
bovine serum albumin, 10 mM carbamylphosphate, and 10 mM of either ornithine or putrescine (as indicated), were incubated 10 min at 37uC. Then
0.1 ml of cold 20% (w/v) trichloroacetic acid was added, and the amount of citrulline or carbamylputrescine, respectively, was determined [9]. The
results show the amount of these ureido compounds in the 0.25-ml incubation mixtures. (B) Inhibition by increasing concentrations of PAPU of the
transcarbamylase activities of E. faecalis PTC using putrescine (closed circles) or ornithine (open triangles) as substrates, and lack of inhibition of E.
faecalis OTC (open squares). Activities are given as a percentage of the activities in the absence of PAPU. A single curve has been fitted to the results
observed for PTC activity with both putrescine and ornithine as substrates.
doi:10.1371/journal.pone.0031528.g002
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below), provided a direct proof that PTC is able to handle
ornithine as substrate.
PTC crystals and diffraction data
Crystal structures (Table 1) of PTC bound either to PAPU
(PTC-PAPU) or PALO (PTC-PALO) at 2.5 and 2.0 A ˚ resolution,
respectively, were obtained. Phasing of the diffraction data for the
PTC-PAPU crystal, using molecular replacement with a poly-
alanine model of one subunit of Pyrococcus furiosus OTC [21]
(pfOTC; 43% identity and 74% identity+similarity for the 315-
residue sequence overlapping in pfOTC and PTC), yielded two
PTC protomers in the asymmetric unit. Molecular replacement
with the refined model for one PTC-PAPU protomer yielded two
trimers in the asymmetric unit of the PTC-PALO crystal. The
same approach was used for phasing of the crystal (diffracting at
1.6 A ˚ resolution) of PTC lacking the C-terminal helix and bound
to PALO (see below and Table 1). All models had excellent Rfree
values and exhibited good stereochemistry, although M125 and
L270, which are involved in putrescine binding (see below) are
outliers in the Ramachandran plot, similarly to the equivalent
OTC residues (L163 and L304 of human OTC, hOTC; unless
indicated, hOTC will be used in all the comparisons with PTC
because of its close structural similarity with it and the report of the
structure of the hOTC-PALO complex [24]). The structure also
encompasses two cis-proline residues, P248 and P271, which are
also involved in the putrescine site.
The PTC subunit
The 8 subunits in the asymmetric units of the PTC-PAPU and
PTC-PALO crystal structures are essentially identical (root mean
square deviation, rmsd, for superimposition of their Ca atoms,
0.15–0.54 A ˚). The largest differences are due to changes in the
active center associated with the binding of the different
bisubstrate analogue inhibitors PAPU or PALO (see below). Each
subunit has a characteristic shape consisting of a hemispheric
Table 1. X-Ray Data and Structure Refinement Statistics.
PTC-PAPU PTC-PALO Truncated PTC-PALO
Data collection
ESRF Beamline BM16 ID23-2 ID14-4
Wavelength (A ˚) 0.980 0.873 0.979
Space group P6322 P1 P6322
Unit cell a, b, c (A ˚) 117.2, 117.2, 225.3 81.5, 81.7, 82.3 90.0, 90.0, 184.3
a, b, c (u) 90, 90, 120 105, 103, 101 90, 90, 120
Resolution range (A ˚)
a 30–2.50 30–2.00 40-1.59
(2.59–2.50) (2.10–2.00) (1.67–1.59)
Reflections, total/unique 692,675/32,509 194,037/114,553 611,850/60,518
Completeness (%)
a 100 (100) 87.5 (79.5) 100 (99.8)
I/s
a 35.1 (9.5) 10.9 (1.8) 5.7 (2.1)
Rsym
b (%)
a 11.5 (42.8) 5.5 (42.5) 8.2 (36.6)
Refinement Statistics
Resolution range 23–2.50 30–2.00 30-1.59
R-factor/Rfree
c 18.7/21.6 19.6/23.7 16.2/18.0
Molecules and atoms refined
Polypeptide chains 2 6 1
Protein atoms 5,422 15,480 2,446
PAPU or PALO 2 6 1
RMSD
d bonds (A ˚)/angles (u) 0.011/1.16 0.008/1.01 0.007/1.13
Average B-factor (A ˚2)
Protein 19.8 33.8 12.7
PAPU or PALO 11.1 30.2 8.5
Ramachandran Plot
e (%)
Favored 93.3 92.2 92.6
Allowed 6.1 7.1 6.4
Generously allowed 0 0 0
Disallowed 0.7 0.7 0.7
aValues in parenthesis are data for the highest resolution shell.
bRsym=SI2,I./SI, where I is the observed intensity and ,I. the average intensity.
cR-factor=Sh IFobs|2|FcalcI/Sh |Fobs|, where |Fobs|a n d| Fcalc| are observed and calculated structure factors amplitudes for all reflections (R-factor). Rfree, R based on 5% of
the data, withheld for the cross-validation test.
dRMSD: root mean square deviation.
eUsing PROCHECK.
doi:10.1371/journal.pone.0031528.t001
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C-terminal helix (helix 13) that, as shown below, is a characteristic
and exclusive PTC feature. The subunit body presents the classical
transcarbamylase fold [3], consisting of two domains of similar size
and gross fold, the N-domain (PTC residues 1–130 and 301–315),
and the C-domain (residues 131–296), corresponding respectively
Figure 3. The PTC protomer structure. (A) Superimposition of Ca trace of the subunit of E. faecalis PTC (blue) with that of hOTC (green, PDB file
1OTH). Black spheres mark every twentieth residue. PAPU (C atoms colored grey) and PALO (C atoms colored green) are depicted in ball and stick
representation, with O and N atoms in red and blue, respectively. (B) Cartoon representation of a PTC protomer of PTC-PAPU, with the ligand in ball
and stick representation. Helices and b-strands are colored orange and turquoise, and labeled, and loops are grey and are labeled when highly
relevant. Helix 13 and the 80-loop of an adjacent subunit are shown colored green and semitransparent. They are marked with asterisks. (C) Close-up
of PAPU bound to PTC. N- and C-domains are shown as transparent surfaces colored blue and pink, respectively, with secondary structure elements
shown below in cartoon representation. The 80-loop* from the adjacent subunit is shown in green and marked.
doi:10.1371/journal.pone.0031528.g003
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ornithine domains of OTC [15]. These domains are folded as
open aba sandwiches nucleated by parallel b sheets (sandwich
composition and b-sheet topologies, a3b5a2 and 1-5-4-2-3,
respectively, for the N-domain; and a3b5a4 and 8-7-6-9-10 for
the C-domain) (Figure 3B). The two domains are interconnected
by helices 5 and 12, with additional interdomain gluing being
provided by helix 1, which runs transversely over helices 5 and 12,
at the interdomain divide on the convex face of the subunit. The
flat face of the hemispheric subunit buries the bisubstrate analog
inhibitor at the interdomain divide (Figure 3B). Characteristically
for transcarbamylases, the b sheets C-edges of both domains look
towards this flat face, and the loops emerging from the b strands
C-ends participate in the active center (Figures 3B and 3C),
including the b5-a5 loop (residues 124–130), the 230-loop
(residues 227–253, including helix 9), the b10-a11 loop (residues
269–279), and the 80-loop* (residues 74–85*) of an adjacent
subunit (an asterisk denotes an element from an adjacent subunit).
The participation of two subunits in the active center supports the
observation made with aspartate transcarbamylase that the
trimeric architecture (see next section) is essential for activity [25].
Although the composition, topology, and even the length of the
secondary structure elements of the PTC subunit are highly similar
to those of the corresponding domains of pfOTC and hOTC
(rmsd for superimposition of the subunits of the PTC-PAPU
subunit excluding the C-terminal a-helix, with those of hOTC-
PALO, 1.27–1.29 A ˚ for 299–300 Ca atoms), there are some
differences with these enzymes (illustrated in Figure 3A for
hOTC). These differences affect particularly the specificity-
determining 230-loop which encompasses helix 9, and the C-
terminus of the subunit, where helix 12 is 1.5-turn longer than in
OTCs and is connected via a 4-residue linker with the already
mentioned extra C-terminal helix (helix 13). The latter 5-turn
helix (residues 320–337) is exclusive of PTC, it is highly
prominent, and it is oriented approximately at a right angle with
respect to helix 12 (Figures 3A and 3B). Helix 13 is projected away
from the subunit, landing on an adjacent subunit, with which it
makes extensive interactions (Figure 4). Although hOTC also
exhibits a C-terminal extension that is not present in bacterial or
achaeal OTCs [24] (Figure 3A), this extension only has 7 residues
instead of the 25 residues of the PTC extension, and it is merely a
loop that does not project away from the subunit, folding over
helix 1 of the same subunit. Nevertheless, as discussed below, this
extension and the C-terminal helix of PTC may share some
functional similarity.
Comparison (using PDBeFold [26], http://www.ebi.ac.uk/
msd-srv/ssm/cgi-bin/ssmserver) of the structure of the PTC
subunit with all the protein structures in the Protein Databank
(http://www.pdb.org/pdb/home/home.do) identified as the clos-
est structures to that of the PTC subunit those of the subunits of
pfOTC, Thermotoga maritima OTC (tmOTC) and hOTC, (Protein
Databank files 1PVV, 1VLV and 1OTH, respectively). This
closeness with OTCs supports our previous suggestion [9] that
PTC might have evolved from an OTC. These three closest
OTCs, as well as PTC, lack an internal helix (called helix 109 or
9a) that is found in some bacterial OTCs of the a-type [27], such
as the E. coli [28] and P. aeruginosa [15] OTCs, two OTCs that are
highly represented in structural databases because of their early
structural study.
The PTC trimer
The application of the crystal symmetry to the two protomers
found in the asymmetric unit of the crystal of PTC-PAPU
generates two trimers. These trimers are essentially identical to the
two trimers found in the asymmetric unit of the crystal of PTC-
PALO (rmsd for superimposition of their Ca atoms, 1.05–1.37 A ˚).
Furthermore, except for the PTC-exclusive C-terminal helix, the
PTC trimer closely resembles the OTC basic trimer (Figure S1)
(rmsd, 1.31–1.37 A ˚ for 894–900 superimposed Ca atoms of PTC-
PAPU with hOTC-PALO, PDB file 1OTH). The trimer is
roughly shaped (Figure 4A) like a triangular shallow cup of ,55 A ˚
deepness and ,50 A ˚ radius from center-to-vertexes. The C-
domains (Figures 4A, B) occupy the three vertexes and protrude
from the cup concave face, the face that hosts the flat faces of the
three subunits and the active centers. The N-domains sit next to
the threefold axis and provide all the intersubunit contacts
excepting those mediated in PTC by helix 13. Interestingly, a
mass of electron density fitting one Ni ion and making the
expected coordinative contacts for such ion is found at the
threefold axis in the trimer convex face in all the PTC crystals
studied here (Figure 4C). The Ni, which is octahedrally
coordinated to three H69 N atoms (one per subunit) and three
O atoms of fixed water molecules (Figure 4C), may have derived
from the Ni-chelate column used for PTC purification. Ni was
found binding in the same site of Lactobacillus hilgardii catabolic
OTC [16]. Given the octahedral coordination that is characteristic
for metals of the transition group II of the periodic table, including
Cd [29], these observations of a metal site in PTC and in at least
one OTC might perhaps explain the reported Cd avidity of liver
OTC [23], rendering important to examine the significance of this
metal site in these enzymes.
A C-terminal helix links adjacent subunits in the PTC
trimer
Helix 13 sits on the next subunit in the anticlockwise direction
(looking from the trimer convex face along the threefold axis,
Figure 4A, right panel), marking in this subunit the interdomain
divide. It covers helix 1 and runs approximately antiparallel to it
(Figures 3B and 5A). In this way, helix 13* forms a protruding
linear ridge in the convex face of each subunit (Figure 4A, center
and right panels), running transversely relative to the radii joining
the threefold axis to the C-domains. The discontinuous wall
formed by these three ridges encircles the three N-domains of the
trimer (Figure 4A right panel and Figure 4B) and gives the PTC
trimer a very characteristic appearance. The presence of this helix
and the shielding by it of helix 1 (Figures 3B, 4B and 5A) is a key
differential feature of PTC relative to any other transcarbamylase
(exemplified in Figure 5B). Furthermore, helix 13 appears to be a
constant PTC feature. Thus, the sequences annotated as PTCs in
protein databases (UniProt, http://www.uniprot.org/; NCBI
Protein, http://www.ncbi.nlm.nih.gov/protein) have C-terminal
extensions sharing a predicted high propensity for a-helix
formation in the region corresponding to helix 13 of E. faecalis
PTC (underlined in the PTC sequences of Figure 5C). Further-
more, these extensions share a weakly diagnostic but constant
signature sequence
330(L/f/v/i/m)XX(F/Y/L/M/v)(L/i/m) (cap-
itals indicate predominance, small case, occurrence with lower
frequency, X, any residue; residue numbering of E. faecalis PTC;
the signature is in red in Figure 5C). Therefore, helix 13 is a
prominent element that appears constant, characteristic and
exclusive of PTCs.
Effects of C-terminal helix deletion
A major role of the C-terminal helix appears to be the
stabilization of the PTC trimer. Thus, ,750 A ˚ 2 and ,610 A ˚ 2 of
helix 13 and of the other subunit body are buried at each helix-
body interface (estimated with a probe of radius 1.4 A ˚). This
interface involves a hydrophobic patch including the conserved
Putrescine Transcarbamylase Structure
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31528Figure 4. Structure of PTC trimer. (A) Surface representations of the trimer along the threefold axis from the concave or convex faces (left and
right, respectively) or with the threefold axis vertical and the concave face up (center). Each protomer is in a different color. (B) Cartoon
representation of the PTC trimer viewed along its threefold axis with its concave face close to the viewer. PAPU is shown in space-filling
representation. Some elements are labeled, and in one protomer the boundary between the N- and C-domains is signaled with a broken line. (C)
Stereoview representation of the electron density omit map for the Ni ion (2.5s) in one trimer of PTC-PALO, showing the coordinated histidine and
water (marked W75, W76 and W512) molecules.
doi:10.1371/journal.pone.0031528.g004
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server (http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver
[30]) gave a much higher energy cost for dissociation to monomers
of the PTC trimer (DG=59 kcal/mol) than of the trimer lacking
this helix (,14.6 kcal/mol) or of the trimer of hOTC (26.4 kcal/
mol), an enzyme that has no C-terminal helix.
We confirmed the decreased stability of the trimer of PTC
lacking the C-terminal helix by deleting this helix. The protein
with this deletion (generated by introducing a stop codon at
position 318) was purified normally from E. coli and gave nearly
normal enzyme activity (619642 U/mg, compared with
670668 U/mg for wild-type PTC). This excludes massive rapid
dissociation of PTC trimers, since transcarbamylases must be
trimeric to be active [25]. Nevertheless, a significant although
small fraction of truncated PTC was eluted as monomers from a
size exclusion chromatography column (Figure 6). Since no
monomer peak was observed with wild type PTC (Figure 6), this
indicates that the truncated enzyme has an increased tendency to
dissociate, as expected. The size exclusion chromatography studies
also revealed the elution of the majority of the truncated enzyme at
a volume expected for hexamers, whereas wild-type PTC was
eluted as trimers (Figure 6). Thus, the C-terminal helix prevents
the association of PTC into hexamers. Supratrimeric architectures
have been reported for pfOTC, which is a dodecameric tetramer
of trimers (Figure 5B, leftmost panel) [21], and for the catabolic
OTCs of Pseudomonas aeruginosa (again a dodecamer) [15] or L.
hilgardii (a hexamer) [16] (Figure 5B, second and third panels from
the left). Helix 1, the helix that is buried in PTC by helix 13, is
centrally involved in the intertrimeric contacts that lead to the
hexamer or dodecamers in these supratrimeric OTCs [15,16,21]
(Figure 5B, details). We confirmed the involvement of helix 1 in
the formation of the hexamers of PTC lacking helix 13 by
crystallizing this truncated enzyme. The crystal structure at 1.6 A ˚
resolution confirmed hexamer formation mediated by intertri-
meric contacts involving helix 1 (Figure 5B, rightmost panel and
detail below it, and S2). Since these contacts are abolished in wild-
type PTC by the presence of helix 13, a function of this helix
appears to be to prevent the formation of supratrimeric
architectures.
The active center and the discrimination between
putrescine and ornithine
The finding in each subunit of the crystals of PTC-PAPU and
PTC-PALO of very elongated masses of non-protein electron
density that fit extended PAPU and PALO molecules (Figure 7A
and 7B), have clarified how can PTC discriminate between
ornithine and putrescine. The active centers of PTC and OTC are
highly similar (Figure 7C). One significant difference is the
replacement by glutamine (Q50) in PTC of a lysine (K88 of
hOTC) that is constantly found in OTCs two positions upstream
of the CP signature STRT (Figure 7C and S2). This replacement
may importantly affect the selectivity for the amine substrate since
the lysine found in OTC helps neutralize the carboxylate group of
ornithine, which is missing in putrescine (Figure 7C). A second
significant change for discrimination between putrescine and
ornithine is the replacement in PTC of the SMG loop of OTC by
the 230-loop (Figure 7C and S2). The sequence and the
conformation of this PTC loop differ importantly from those of
Figure 5. Helix 1, helix 13, and presence or absence of supratrimeric oligomerization in OTC and PTC. (A) Cartoon representation of
helix 1 (in orange) and H13* of the adjacent subunit (in dark green) showing residues involved in the contacts between these helices. (B) Oligomeric
structures of (from right to left): pfOTC (PDB file 1PVV), Pseudomonas aeruginosa OTC (1DXH), Lactobacillus hilgardii OTC (2W37), hOTC (2OTH) and E.
faecalis truncated PTC. For each structure, the biological assembly is shown in the top part, with each basic trimer encircled in a broken line, focusing
in the bottom part on the interactions of helix 1. In hOTC the surface of a subunit is shown in semitransparent representation and helix 1 in illustrated
in cartoon form. The color code of the helices shown in the bottom part corresponds to that of the subunits involved in the interactions shown. (C)
Sequence alignment of the C-terminal portions of OTCs of known 3-D structure and of representative known or putative PTCs (annotated as such in
UniProt and NCBI Protein databases). Red lettering marks the PTC sequence signature identified in helix 13. Underlining marks experimentally
observed (OTCs and E. faecalis PTC) or predicted (other PTCs) a-helices. Secondary structure was predicted with SOPMA (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_sopma.html). PDB files are the following for OTCs: human, 1OTH; Ovis aries, 1FB5; Coccidioides immitis, 3SDS;
P. furiosus1PVV; Mycobacterium tuberculosis, 2I6U; Gloeobacter violaceus, 3GD5; Thermus thermophilus, 2EF0; Giardia lamblia, 3GRF; E. coli, I form, 2OTC;
P. aeruginosa, 1DXH; L. hilgardii, 2W37; Thermotoga maritima, 1VLV; Campylobacter jejuni, 3TPF. For PTCs, UniProt or NCBI Protein database entries are
the following: E. faecalis, Q837U7; Eggerthella lenta, C8WMM1; S. mutans, Q8DW19; L. monocytogenes, D2P024; Pediococcus pentosaceus, Q03HM9;
L. hilgardii, C0XJB3; Vibrio sinaloensis, E8M734; Mycoplasma mycoides, Q6MSR6; Slackia heliotrinireducens, YP_003143629.1; Photobacterium
profundum, YP_133569.1; Caulobacter sp., YP_001684585.1; Parvibaculum lavamentivorans, YP_001412420.1.
doi:10.1371/journal.pone.0031528.g005
Figure 6. Size exclusion chromatography of wild type and
truncated PTC. Lower panel: Optical density at UV
280 of the effluent of
the Superdex 200HR column after injection of wild-type E. faecalis PTC
(red) or of this enzyme lacking helix 13 (blue). Top, semilogarithmic plot
of molecular mass versus elution volume for marker proteins (see
Materials and Methods) and for the observed peaks if they correspond-
ed to trimers or wild type PTC (red square, sequence-deduced mass for
a trimer, 120.3 kDa), or to truncated PTC hexamers (blue triangle,
sequence-deduced mass for the hexamer, 230 kDa) and monomers
(blue inverted triangle; sequence-deduced mass, 38.3 kDa). The inset
shows Coomassie stained SDS-PAGE of purified wild type (WT) and
truncated (Trun) PTC, together with marker proteins (St) with masses in
kDa.
doi:10.1371/journal.pone.0031528.g006
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OTC by the PTC signature
227DVWYGLY
233 (underlined
residues are constant or conservatively replaced in PTCs). The
influence of this last loop in the selectivity of PTC for putrescine is
illustrated by the interactions with putrescine of Y233. In the
narrow and mainly hydrophobic sheath that encircles the
putrescine moiety of PAPU (Figure 7D), the phenolic ring of
Y233 sits flat as a tile at the site that would be occupied by the a-
COO
2 of ornithine, hampering ornithine but not putrescine
binding (Figures 7C–E). This phenolic ring is stabilized in such
position by hydrophobic contacts with nearby residues and with
the hydrocarbon chain of putrescine, as well as by hydrogen
binding of its O atom with the side-chain N atom of Q79* from
the 80-loop* of an adjacent subunit (Figure 7E). In contrast, in the
PTC-PALO complex the phenolic group of Y233 is far from the
ornithine and it interacts extensively with the carbon chain of Q50
(Figure 7E), leaving widely exposed the ornithine moiety of PALO.
This loss of extensive contacts with the hydrocarbon chain of the
bound ornithine should strongly decrease the stability of the
enzyme-ornithine complex and thus the affinity for ornithine, as
reflected in the much larger Km value of PTC for ornithine than
for putrescine (1.460.2 mM for putrescine and 36.463.5 mM for
ornithine, our own data; see also [7]).
A change in the position of Y233 in the PTC-PALO complex
may also account for the decreased kcat of PTC for ornithine [7].
In this complex the hydrogen bond between the Y233 phenolic O
atom and Q79* is lost and the position of Q79* and of the 80-
loop* is changed (Figure 7E). Q79* is crucial for formation by the
80* and 230 loops of a roof over the active center that buries the
bound PAPU, and that must be opened and closed in each
catalytic cycle to allow substrate access and product release. The
roof opening an closing cycle and the catalytic cycle may be
synchronized by the hydrogen binding of this N atom of Q79*
with an O atom of the phosphonate moiety of PAPU and thus of
CP (Fig. 7E). Actually, this hydrogen bond links one subunit with
the substrate bound to another subunit, supporting the view that in
PTC, as in other transcarbamylases, two subunits are needed for
building the active center (Figure 7C). In any case, the roof over
bound PAPU involves the cooperation of both subunits. Although
the side chain O atom of Q79* is hydrogen-bonded to one N atom
of the imidazole ring of H83* belonging to the 80-loop*, the other
N atom of this imidazole is bound to the side-chain carboxylate of
E236, of the 230-loop of the subunit hosting the active center
(Figure 7E). The breaking of the roof may be deleterious for
enzyme activity if catalysis requires confinement of the substrates
under this closed roof. Indeed, the abolition in the PTC-PALO
complex of the hydrogen bond between the phenolic O atom and
Q79* also results in the secondary loss of the hydrogen bond
linking Q79* and H83* (Figure 7E), tearing open at its center the
roof over the active center, clearing the way to allow the escape of
ornithine. Actually, of the six PTC subunits in the asymmetric unit
of the PTC-PALO complex, the 80-loop is not visible in three of
them and the 230-loop in two, indicating mobility or disorder of
these loops, reflecting the roof-destabilizing effect of the loss of
hydrogen bonds caused by the mispositioning of Y233 resulting
from ornithine binding. In contrast, both subunits found in the
asymmetric unit of the PTC-PAPU complex have well conformed
roof and loops over the bound PAPU. Since the residence time of
the substrates in the active center might determine the probability
of reaction, the tearing or opening of the roof in the complex with
ornithine may decrease this residence time and reduce the Vmax
with ornithine, as observed experimentally (813638 U/mg for
putrescine and 2461 U/mg for ornithine, Figure 8).
Engineering of the 230-loop of PTC favors the use of
ornithine and impairs that of putrescine
We tested the effect of replacing the sequence
230YGLY
233 of
the putrescine signature of E. faecalis by its OTC counterpart
VSMG. The engineered enzyme, produced recombinantly and
purified similarly to the wild-type enzyme, exhibited a dramatic
reduction in its activity with putrescine (Figure 8). This reduction
was due to a drastic reduction in the velocity at saturation of
putrescine (from 813638 U/mg to 1.1360.13 U/mg) together
with a ,20-fold increase in the apparent Km for putrescine (from
1.4160.22 mM to 32.968.8 mM) (Figure 8). These findings
highlight the importance of this loop for putrescine binding and for
determining the rate of the reaction. In contrast with this
impairment of the ability of the enzyme to use putrescine, the
Figure 7. Binding of PAPU and PALO to PTC and comparison with PALO binding to OTC. (A and B) Electron density Fo-Fc omit maps
(2.5s) for PAPU or PALO in the PTC-PAPU (A) or PTC-PALO (B) crystals. The protomer hosting the binding site is shown in green, labeling some nearby
secondary structure elements, while the 80-loop* of the neighboring subunit is represented in blue. (C) Stereoview of active centers of PTC (blue) and
hOTC (green) with, respectively, PAPU and PALO (represented as balls and sticks). Elements of the 80-loop* of the adjacent subunit is illustrated with
C atoms in red and pink for PTC and OTC, respectively. (D) Longitudinal section of the PAPU binding site in PTC, showing in the surface the sulfur,
carbon, oxygen and nitrogen atoms of the protein colored in yellow, white, red and blue, respectively. PAPU is shown in ball and stick representation
with the Van der Waals spheres of its atoms shown dotted. (B) Stereoview of active centers of PTC-PAPU (blue) and PTC-PALO (orange), with bound
PAPU (blue) and PALO (grey) represented as balls and sticks. The 80-loop* of the adjacent subunit is illustrated in red and light blue for PTC-PAPU and
PTC-PALO, respectively. Some hydrogen bonds forming a roof over the active center that are affected by the binding of PALO are shown as dashed
lines.
doi:10.1371/journal.pone.0031528.g007
Figure 8. Changes in PTC specificity by engineering the 230-
loop. Putrescine (circles) or ornithine (squares) concentration depen-
dency of enzyme activity for wild type PTC (WT, open symbols) and for
the engineered form in which the
230YGLY
233 sequence was replaced by
VSMG (Engineered, closed symbols). WT activity is plotted in the left y-
axis whereas other activities are plotted on the right y-axis. Inset: zoom
on the engineered form with putrescine.
doi:10.1371/journal.pone.0031528.g008
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mainly because of a ,3.5-fold increase in the velocity at saturation
of ornithine (from 2461 U/mg for wild-type PTC to 8263 U/mg
for the engineered enzyme), with only a minor decrease in the
apparent Km value for ornithine (from 36.463.5 mM to
32.062.0 mM) (Figure 8). In summary, this change in the loop
decreased the catalytic efficiency (Vmax/Km) of the enzyme
for putrescine from a value of 577 U mg
21 mM
21 to
0.03 U mg
21 mM
21, whereas it increased the catalytic efficiency
for ornithine from a value of 0.67 U mg
21 mM
21 to
2.6 U mg
21 mM
21, rendering the enzyme a better ornithine
transcarbamylase than putrescine transcarbamylase. These results
confirm the importance of the 230-loop in the discrimination
between putrescine and ornithine.
A structure-based simple signature for PTC identification
from its sequence
For many years the gene for PTC could not be differentiated in
genomic databases from that of OTC. However, bibliographic
datamining led to the rediscovery [20] of the N-terminal sequence
of E. faecalis PTC [31], allowing identification of the PTC gene in
this organism, and by sequence alignment, in other organisms
[20,32]. From the comparison of these sequences, 5 long motifs
were proposed as characteristic of PTCs [20]. By using the present
structural information we can provide a simplified signature for
PTC identification. PTC sequences can be recognized because
they have the invariant
52STRT and
268HCLP (numbering is for
E. faecalis PTC) sequences for, respectively, CP and ornithine/
putrescine binding (shared also by OTCs) but they lack the lysine
found in OTCs two residues upstream of the
52STRT sequence, a
lysine that is involved in OTCs in ion pairing with the a-COO
2
group of ornithine. In addition, about 40 residues upstream of the
invariant HCLP sequence of PTCs and OTCs, the characteristic
XSMG sequence of OTCs that gives its name to the SMG loop of
these enzymes is replaced in PTCs by the specificity-determining
230 loop sequence
230(Y/W)(G/W)(V/L/I)X. Additional charac-
teristic traits of PTCs are provided by the finding of a ,20-residue
C-terminal extension when the sequence is aligned with that of an
OTC, and by the finding within this extension of the signature
identified above in the C-terminal helix,
330(L/f/v/i)XX(F/Y/L/
M/v)(L/i/m).
Final remarks
The incomplete differentiation between putrescine and orni-
thine by PTC, and the close similarity of the sequences as well as
the structures of PTC and OTC [20] indicate that these two
enzymes are highly related, possibly having diverged relatively
recently [9]. The time from divergence may have been too short to
allow PTC to perfect a strict specificity for putrescine. This recent
divergence of PTC and OTC contrast with the much more
extensive and, most likely, much earlier divergence of two other
components of the same operon, the agmatine deiminase (AgDI)
and agmatine/putrescine antiporter, from the corresponding
components of the analogous arginine deiminase (ADI) operon
of arginine catabolism (Figure 1A and B) [9]. Thus, it appears
unlikely that the AgDI pathway arose from an ‘‘en bloc’’
duplication of the operon for the ADI pathway, favoring the view
that the AgDI gene cluster was pasted together from its isolated
components. The essentially identical gene composition and
organization of this gene cluster in the organisms in which a
PTC has been annotated [19,20,31,32] indicates a relatively
recent single-time origin of the cluster, which has.spread to
relatively few organisms compared with the more widespread ADI
gene cluster (see for example the Comprehensive Microbial
Resource of JCVI, http://cmr.jcvi.org/tigr-scripts/CMR). This
restricted distribution perhaps reflects a recent origin (less time to
spread) and the more limited occurrence of agmatine than
arginine in bacterial environments (see for example [33]).
Given the particularly close similarity in sequence and structure
of pfOTC and PTC, it is tempting to propose that both share a
hyperthermophilic archaeal ancestry. The relatively low specific
activity of PTC (,700 U/mg at 37uC) compared with typical
OTCs (,4000 U/mg at 37uC [34,35]) may be a reminiscence of a
hyperthermophilic origin, since typically hyperthermophilic en-
zymes have low specific activities at mesophilic temperatures [36],
as is the case for pfOTC [37]. A hyperthermophilic origin could fit
the need for the extra (relative to all other transcarbamylases) C-
terminal helix (helix 13) found in PTC. The pfOTC trimer, when
isolated from its dodecamer which is essential to give this enzyme
its resistance to high temperatures [21,38], is predicted to have
relatively low stability (DG for dissociation, 12.8 kcal/mol,
estimated with the PISA server), compared with typical mesophilic
OTC trimers (for example, estimated DG for dissociation of
hOTC, 26.4 kcal/mol). In the pfOTC dodecamer the trimer is
stabilized by the links between subunits from adjacent trimers
through hydrophobic contacts and ion-pairs mainly mediated by
helix 1 [21]. Therefore, to make posible its existence as an isolated
trimer, the potential hyperthermophilic ancestor of PTC had to
replace helix 1-mediated intertrimeric contacts by contacts
mediated by the novel subunit-subunit interlinking C-terminal
helix (Figure 5A). In this way, helix 13 plays the dual role of
stabilizing the trimer and of preventing supratrimeric association.
If PTC derives from an ancestral hyperthermophilic enzyme
having a dodecameric architecture, as pfOTC, it is uncertain
which was the selective pressure for eliminating this supratrimeric
organization, particularly since a change to trimeric architecture
decreases the stability of the trimer, making necessary to
incorporate the C-terminal helix for increasing stability. Perhaps
such type of organization could restrict domain movements,
known to be important in transcarbamylases including OTC
[3,28,39]. However, in pfOTC the dodecameric architecture does
not appear to hinder the approach of the C-terminal domain to
the N-domain that is associated with catalysis [40]. Another
disadvantage of a stable supratrimeric organization could be a
tendency to en bloc degradation of the whole oligomer when one of
the trimers forming it is damaged as per oxidative or proteolytic
damage. Perhaps the most attractive reason against supratetra-
meric organizations would be if this organization would not be
compatible with formation of a metabolon involving AgDI, PTC
and the agmatine/putrescine antiporter at the bacterial mem-
brane. Such complex would make sense for highly efficient
fermentation of the agmatine in the medium, which would be used
as soon as it is internalized. Agmatine is a precursor of polyamines
[41], and the restriction of its fermentative use to the agmatine
crossing the bacterial membrane would prevent affectation of
intracellular polyamine pools and even the fermentative consump-
tion of endogenously generated agmatine. The participation of
PTC in a supramolecular complex would not be an exceptional
case among transcarbamylases. In some bacteria aspartate
transcarbamylase makes a complex with the next enzyme in the
pyrimidine biosynthesis pathway [42], and in animals it belongs to
a large multifunctional protein (CAD) catalyzing the initial three
steps of pyrimidine synthesis [43].
Whichever the reasons for choosing a trimeric rather than a
supratrimeric organization in PTCs, the use of novel secondary
structure elements such as the C-terminal helix of PTC to prevent
oligomerization is not without precedent, having been reported,
for example, in type III aspartokinase [44]. This enzyme
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in all other known members of the amino acid kinase family for
interaction with another subunit. In this way, this novel helix
hairpin prevents intersubunit contacts via this surface [44].
Although the C-terminal helix of PTC appears restricted
exclusively to this type of transcarbamylase, the structure of
hOTC suggests that a helix 1-shielding strategy has been used by
this enzyme for avoiding supratrimeric oligomerization. hOTC
has a shorter (relative to PTC) C-terminal extension [24] that is
not projected towards the adjacent subunit but that crosses
transversally helix 1 of the same subunit, thus being expected to
prevent intertrimeric interactions (Figure 5B, 2nd panel from right
and detail below it). This finding, and that in PTC of a C-terminal
helix that prevents supratrimeric oligomerization renders impor-
tant to examine further the roles of supratrimeric organizations
among transcarbamylases.
Materials and Methods
Wild type and engineered enzymes
Pure recombinant E. faecalis PTC having the C-terminal His6
extension SAAKLAAALEH6 was prepared, and E. faecalis OTC
(specific activity, 4021 U/mg) was obtained, as reported [9]. PTC
carrying the R54G mutation was prepared from pET-PTC [9], using
the Quickchange site-directed mutagenesis kit (from Stratagene) and
the oligonucleotide pair 59-AATCTTCAACTGGCACACGAG-
TATCTTTTGAAAC-39 and 59-GATACTCGTGTGCCAGTT-
GAAGATTGTTGGAAA-39 (underlining indicates mutated bases).
The same strategy was used for changing the sequence of the 230-
loop form
230YGLY to
230VSMG, using as mutagenic primers 59-
CGGATGTTTGGGTGTCCATGGGTGAAGCGGAATTATC
TGAAGAA-39 and 59-AATTCCGCTTCACCCATGGACACC-
CAAACATCCGTGTACAAC-39. The presence of these mutations
was confirmed by sequencing. The procedure for expression and
purification of these mutant proteins, and their final purities (assessed
by SDS-PAGE) and yields were similar to those for wild-type PTC.
For deletion of the C-teminal helix of PTC, the region of the
ef0732 gene encoding amino acids 1–317, followed by a stop
codon, was PCR-amplified from E. faecalis SD10 genomic DNA
[9] using a high-fidelity thermostable DNA polymerase (Deep
Vent; New England Biolabs) and the primer pair 59 TACTTC-
CAATCCATGAAAAGAGATTACGTTAC-39 and 59 TA
TCCACCTTTACTGTCAAATGCTTTGAGTGTCTAAG-39,
(bold-type, PTC-coding sequences, underlined, stop codon). The
product was incorporated in the cloning vector pNIC28-Bsa4 (a
gift from O. Gileadi, Oxford University, UK) by ligation-
independent cloning using T4 DNA polymerase [45]. The
resultant plasmid carrying the truncated gene, isolated from
DH5a cells and confirmed by sequencing to carry the correct
construct (including a sequence that encodes the N-terminal His6
tag MH6SSGVDLGTENLYFQS) was transformed into BL21
(DE3) cells (from Novagene) that were co-transformed with
pGroESL. The latter plasmid is a pACYC184-derived expression
plasmid (provided by A. E. Gatenby, DuPont de Nemours,
Wilmington, DE) that encodes the E. coli chaperonins GroES and
GroEL [46]. After growth of the cells at 37uCt o,0.7 OD600 in
liquid LB supplemented with kanamycin (0.04 mg/ml) and
chloramphenicol (0.035 mg/ml), 0.1 mM isopropyl ß-D-thioga-
lactopyranoside was added and the culture was continued
36 hours at 20uC. Cell harvesting, disruption and purification of
the protein at 4uC using Ni-based chromatography were as for the
wild-type enzyme [9].
Crystallization and data collection
The crystals of PTC-PAPU, of ,0.3 mm largest dimension and
hexagonal prismatic habit, were obtained as reported [9] at 294 K
by the vapor diffusion technique in hanging drops prepared in 24-
well plates by mixing 1 ml of a crystallization solution composed of
125 mM (NH4)2SO4, 17% polyethylene glycol (PEG) 3.35 K
(from Hampton Research), 0.1 M bis-Tris, pH 5.5, and 1 ml of 10-
mg ml
21 PTC in 50 mM Tris-HCl, pH 7.5 containing 0.43 mM
PAPU [9]. Crystals of wild-type and truncated PTC with PALO
were obtained at 21uC by vapor diffusion in 96-well plates, in
0.8 ml sitting drops dispensed with a HoneyBee X8 robot
(Genomics Solutions) using commercial screens (from Hampton
Research and Jena Bioscience). The best crystals for the wild type
enzyme (maximal dimension, 0.1 mm, and similar habit to the
PTC-PAPU crystals) were obtained in 1/1 drops of a solution of
PTC (7.5 mg ml
21) in 50 mM Tris-HCl pH 7.5 containing 1 mM
PALO (a gift of D. Shi, Children’s Research Institute, Washington
DC) and of a crystallization solution containing 0.2 M NH4
acetate, 25% PEG 3.35 K, 0.1 M bis-Tris, pH 5.5. The best
crystals for truncated PTC (maximal dimension 0.2 mm) were
obtained using a crystallization solution consisting of 0.2 M
MgCl2, 30% PEG 0.4 K, 0.1 M Hepes, pH 7.5. While for
freezing PTC-PAPU and PTC-PALO crystals the cryobuffer was
reservoir solution enriched with 15% or 20% glycerol, respective-
ly, the truncated PTC-PALO crystals were flash-cooled in liquid
nitrogen without cryoprotectant.
The crystals were diffracted at 100 K (Oxford Cryo-Systems)
(Table 1) using synchrotron radiation (ESRF, Grenoble, France;
beamlines are detailed in Table 1). The dataset for PTC-PAPU
was processed and scaled with DENZO and SCALEPACK
(HKL-2000 program package [47]) and imported to CCP4 [48]
with SCALEPACK2MTZ and TRUNCATE (CCP4 suite [48]).
The data for the other two crystals were processed with
MOSFLM, SCALA and TRUNCATE (CCP4 suite [48]). Data
collection and refinement statistics are shown in Table 1.
Phasing, model building, and refinement
Molecular replacement using MOLREP (CCP4 suite [48]),
utilizing a polyalanine model of the subunit of Pyrococcus furiosus
OTCase (PDB file 1A1S, [21]) yielded a satisfactory solution for
the PTC-PAPU crystal, consisting of two subunits in the
asymmetric unit. Rigid-body and restrained refinements were
performed using REFMAC5 [49], alternating with graphic model-
building sessions with the program COOT [50]. B-factors and
positional non-crystallographic symmetry restraints were used and
gradually released as refinement progressed. All the diffraction
data were used throughout the refinement process except the 5%
randomly selected data used to calculate the Rfree [51]. Refinement
converged to a final R-value of 18.7% (Rfree=21.6%). The final
model, at 2.5-A ˚-resolution, consisted of two chains, each one
encompassing residues 1 to 340 and containing a bound molecule
of PAPU. The stereochemistry of the model, checked with
PROCHECK [52], was good, with only two residues (Met125
and Leu270) in the disallowed region. Table 1 summarizes the
data on the refinement process and on the final model. PAPU was
built in the non-protein density observed at the active center, by
taking one PALO molecule from the structure of E. coli OTC
bound to PALO (PDB accession number 2OTC), then removing
the carboxylate group of the ornithine moiety to build the PAPU,
and then placing this molecule manually within the observed
electron density, finally refining ligand and protein with
REFMAC5. TLS was used in the last steps of refinements [53]
using the TLSMD server (http://skuld.bmsc.washington.edu/
,tlsmd/, [54]) for choosing the TLS groups.
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molecular replacement was performed with MOLREP using the
PTC-PAPU devoid of PAPU as a model. Helix 13 was removed
from the model for phasing of the truncated protein crystal. The
number of subunits in each asymmetric unit is given in Table 1.
Model building and refinement were carried out as for PTC-
PAPU. One molecule of PALO per subunit was found in the PTC-
PALO complexes. R, Rfree values and the stereochemistry were
excellent in the two cases, with the same two residues as above in
the disallowed region.
Other methods
PTC activity was assayed as previously described [9] at 37uCi n
50 mM Tris-HCl pH 7 in the presence of 10 mM putrescine and
10 mM CP, determining carbamylputrescine production. The
OTC activity of PTC was determined in the same way, replacing
putrescine by ornithine and using the Tris-HCl at pH of 8.5. With
both activities, when the concentration of one substrate was
varied, the other was kept constant at 10 mM. Substrate
concentration-activity data were fitted to hyperbolae using
program GraphPad Prism (GraphPad Software, San Diego, Calif).
One enzyme unit corresponds to the production of 1 mmol
carbamylputrescine min
21.
Analytical size exclusion chromatography of PTC (wild-type o
truncated) was performed by injecting 20 ml of a 10 mg/ml
solution of the protein to a Superdex 200HR 5/150 GL column
fitted in an A ˚kta FPLC and equilibrated and eluted (flow rate,
0.25 ml min
21)a t2 4 uC with 50 mM Hepes pH 7.5, 0.25 M
NaCl, monitoring optical absorption at 280 nm. The column was
calibrated with the following protein standards of known mass
(given in kDa): thyroglobulin (669), ferritin (440), amylase (223.8),
Thermotoga maritima acetylglutamate kinase (182), bovine serum
albumin (66.4), carbonic anhydrase (29) and ribonuclease (13.7).
Protein was assayed by the method of Bradford [55], using a
commercial reagent from Bio-Rad and bovine serum albumin as a
standard. SDS-PAGE was carried out as described by Laemmli
[56]. Sequence alignments were carried out with ClustalW [57],
using default values. Superposition of structures was carried out
with the program SSM [26]. Buried surface areas were calculated
using NACCESS (http://wolf.bms.umist.ac.uk/naccess). Figures
of protein structures were generated using Pymol (http://pymol.
sourceforge.net/).
Atomic coordinate and structure factor accession
number
The coordinates and structure factors have been deposited in
the Protein Data Bank (http://www.rcsb.org/) with the accession
codes 4A8H, 4A8P and 4A8T for PTC-PAPU, PTC-PALO and
truncated PTC-PALO, respectively.
Supporting Information
Figure S1 Superimposition o PTC and hOTC trimers.
Stereoview of Ca trace of E. faecalis PTC (blue) and human OTC
(green) trimers viewed along the 3-fold axis. PAPU and PALO are
depicted in ball and stick representation.
(TIF)
Figure S2 Alignment of PTC and hOTC sequences and
structures. Horizontal arrows and open cylinders above and
below the sequences denote respectively a-helices and b-strands.
Since each subunit interacts with two different subunits in the
trimer, triangles and circles indicate residues interaction with one
and the other neighboring protomers, respectively, whereas
squares denote residues that contact both adjacent protomers.
These symbols are open when these contacts only take place in
PTC, and filled when they interact both in PTC and OTC. Grey-
filled rhombi denote residues that interact with PAPU in PTC-
PAPU and with PALO in hOTC, whereas open rhombi only
interact with the bisubstrate analog in PTC. Vertical arrows
indicate residues corresponding to those involved in intertrimeric
interactions in pfOTC (black-bordered) or in L. hilgardii (blue-
filled). Asterisks denote identity between the sequences shown.
White residues on black backgrounds are those invariant among
PTCs or among OTCs, whereas those on grey background exhibit
conservative replacement within one or the other transcarbamyl-
ase family. The STRT, HPXQ and HCLP motifs are encased in
squares colored pink, blue and orange, respectively. The
mitochondrial signal peptide is underlined in the hOTC sequence.
The OTC sequences that were aligned correspond to the following
Uniprot accession numbers: P00480, P08308, P44770, P21302,
P04391, Q8XCB8, Q08016, Q8EVF5, P59779, P96108, P68746,
P75473, Q59283, P0A5M9, Q55497, P11724, Q02047, Q43814,
Q48296, P96172, P18186, Q51742, P96134, Q5829, P11066,
Q00291, P11803, P14995, P05150, P31317, P31326, P11725,
P00481 and P00480). The PTC sequences that were aligned
correspond to the following Uniprot accession numbers Q837U7,
C8WMM1, Q8DW19, D2P024, Q03HM9, C0XJB3, E8M734,
Q6MSR6, B7S4N1, C9QF99, D0AI19, Q03NG2, C0WN35,
Q38ZL1, Q2SRJ4, F8K6E0, Q03HM9; and to the following
NCBI entries: YP_003143629.1, YP_133569.1, YP_001684585.1,
YP_001412420.1, ZP_08712612.1, ZP_08723343.1, YP_001412420.1
and YP_003181041.1.
(TIF)
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